SCHEMBL4453918

SCHEMBL4453918

COCc1ccccc1-c1ccc(O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.51
ABCB1 P08183 2/20 0.51
BCR P11274 2/20 0.51
ESR2 Q92731 2/20 0.43
FFAR1 O14842 4/20 0.43
FFAR4 Q5NUL3 4/20 0.43
PDK2 Q15119 1/20 0.42
MMP3 P08254 1/20 0.41
BCL2L1 Q07817 1/20 0.41
PDE4A P27815 2/20 0.41
PDE4B Q07343 2/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 2/20 0.41
KCNN4 O15554 1/20 0.40
DPP4 P27487 1/20 0.39
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
MGAM O43451 2/20 0.39
GAA P10253 2/20 0.39
SI P14410 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL792032 0.86 DPP4 (0.54) FFAR1FFAR4PDK2KCNN4DPP4
SCHEMBL29788053 0.86 DPP4 (0.54) FFAR1FFAR4PDK2KCNN4DPP4
SCHEMBL1338590 0.85 FFAR1 (0.46) FFAR1FFAR4PDK2KCNN4DPP4
SCHEMBL10981077 0.84 ABL1 (0.50) ABL1ABCB1BCRESR2FFAR1
SCHEMBL24196076 0.83 FFAR4 (0.39) ABL1ABCB1BCRFFAR1FFAR4
SCHEMBL10252337 0.83 FFAR1 (0.48) FFAR1FFAR4PDK2KCNN4DPP4
SCHEMBL8729686 0.83 DPP4 (0.42) FFAR1FFAR4PDK2KCNN4DPP4
SCHEMBL2034604 0.81 FOLH1 (0.52) FFAR1FFAR4KMT2A
SCHEMBL734879 0.81 KCNN4 (0.46) PDK2KCNN4DPP4KMT2A
SCHEMBL21247561 0.81 ABL1 (0.43) ABL1ABCB1BCRESR2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GILLESPIE PAUL 2009-06-18 US disclosed
US-7524870-B2 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators HOFFMANN-LA ROCHE INC. (US) 2009-04-28 US disclosed
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GILLESPIE PAUL 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GYS2, GYS1, GSK3A ABL1 4376/4885ABCB1 1315/4885BCR 4350/4885
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GYS2, GYS1, GSK3A ABL1 4376/4885ABCB1 1315/4885BCR 4350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.